Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
This helps control post-meal blood sugar spikes and increases satiety
Diabetes promotes the progression of MASLD to steatohepatitis, cirrhosis, and hepatocellular carcinoma
J Clin Endocrinol Metab 99(7):24772485
It can be most helpful for people who struggle with the GI-related side effects of these drugs, as well as those looking for more gradual weight loss or who want to taper off a GLP-1 without risking weight regain
When blood sugar rises after a meal, GLP-1 amplifies the pancreas's insulin response
GLP-1s approved for diabetes include Mounjaro (tirzepatide), Ozempic (semaglutide), Rybelsus (oral semaglutide), Trulicity (dulaglutide), and Victoza (liraglutide)
US$ 27.11
US$ 29.72
US$ 21.71
US$ 27.07
US$ 26.96
US$ 23.96
US$ 28.05
US$ 28.79
